Results 11 to 20 of about 34,791 (213)

Faktor-Faktor Yang Berhubungan Dengan Ibu Hamil Dalam Melakukan Imunisasi Tetanus Toxoid

open access: yesCitra Delima, 2022
Imunisasi Tetanus Toxoid (TT) adalah toksin kuman tetanus yang telah dimurnikan yang di berikan pada bayi, anak dan ibu sebagai usaha memberikan perlindungan terhadap penyakit tetanus Imunisasi Tetanus Toxoid ini juga diberikan pada ibu hamil dan wanita ...
desti widya astuti
doaj   +1 more source

Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019

open access: yesAJPM Focus, 2023
Introduction: Vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during pregnancy is highly effective against Bordetella pertussis in young infants.
Cheryl J. Isenhour, DVM   +4 more
doaj   +1 more source

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents

open access: yesInternational Journal of Infectious Diseases, 2020
Objective: To determine the seroprevalence of antibodies against of diphtheria, tetanus, and pertussis among Thai adolescents. Methods: A cross-sectional study was conducted among Thai adolescents aged 11–20 years who had completed five doses of ...
Pimpika Hanvatananukul   +7 more
doaj   +1 more source

Tetanus-Toxoid Vaccination among Married Women of Reproductive Age (18-49) and its Association with Socio-demographic in Union Council Kamu Shaheed District Ghotki Sindh [PDF]

open access: yesJLUMHS, 2019
OBJECTIVE: To determine the factors in influencing for tetanus toxoid vaccination among married women of reproductive age group (18-49) of Ghotki Sindh.
Abdul Wahab Somoro   +5 more
doaj   +1 more source

The monoclonal antibody 26 raised against tetanus toxoid also recognizes tetanus toxin and β2-glycoprotein I - its binding properties in vitro and potential applications [PDF]

open access: yesJournal of the Serbian Chemical Society, 2009
A murine monoclonal IgG1 antibody, marked as MAb26, specific for tetanus toxoid has been immunochemically characterized. By performing enzyme-linked immunosorbent assays (ELISAs) and western blot analyses, it was demonstrated that MAb26 reacted with ...
Inić-Kanada Aleksandra B.   +4 more
doaj   +1 more source

Clinical Profile, Management and Outcome in Paediatric Patients with Tetanus: A Case Series [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Tetanus is an acute infectious disease, caused by spores of the bacterium Clostridium tetani. The spores are found everywhere in the environment, particularly in soil, ash, intestinal tracts/faeces of animals and humans, on the surfaces of skin and rusty
Arpita Manish Patel   +4 more
doaj   +1 more source

A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody. [PDF]

open access: yes, 2015
The CCR5 receptor plays a role in several key physiological and pathological processes and is an important therapeutic target. Inhibition of the CCR5 axis by passive or active immunisation offers one very selective strategy for intervention.
Akthar, S   +12 more
core   +11 more sources

Current state of methods for control the safety and potency of diphtheria toxoid and tetanus toxoid in combined vaccines

open access: yesЭпидемиология и вакцинопрофилактика, 2022
Relevance. Diphtheria toxoid (DT) and tetanus toxoid (TT) manufacturing appears as many steps process. On every stage of proceeding vaccine the control of critical points is being provided.
E. I. Komarovskaya, O. V. Perelygyna
doaj   +1 more source

A Vaccine Against Group B Streptococcus: Recent Advances [PDF]

open access: yes, 2020
Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally. Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and infant GBS disease and has been identified as a priority by the World ...
Carreras-Abad, C   +3 more
core   +2 more sources

Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model

open access: yesFrontiers in Immunology, 2020
Cervical cancer is the fourth most common cancer in women with an estimated 570,000 new cases in 2018 which constitute about 6. 6% of all cancers in women according to WHO report 2018.
Donia Alson   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy